Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Injury and Ketamine (BIKe)
2023-505319-19-00Phase 4Authorised
- Sponsor
- UZ Leuven
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketamine in traumatic brain injury (TBI) and intracranial hypertension (IH) (2 arms), sponsored by UZ Leuven. Primary endpoints: Reduction in cumulative daily Therapy Intensity Level (TIL) score and Number of high intracranial pressure episodes. Planned start Feb 2024; status: authorised.
02
Drugs
ketamine
03
Conditions
traumatic brain injury (TBI)intracranial hypertension (IH)
Beyond the preview
Go deeper on 2023-505319-19-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505319-19-00.